A Clinical and animal study on Kasa Roga (disease characterized with Cough) and Vyadhikshamatva (Immunity) in children with an Ayurvedic medicine- Kasahara Dashemani Vati

A Pharmaco-Clinical Study on Kasa and Vyadhikshamatva in Children with Kasahara Dashemani Vati - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2011/10/002062

Enrollment

Registered

2011-10-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Kasa (recurrent cough)

Interventions

Intervention1: Kasahara Dashemani Vati 500mg 8 weeks: dosage according to body weight (Clark?s rule with 12 grams as adult daily dose) thrice daily after food with honey for a duration of 8 weeks Inte

Eligibility

Inclusion criteria

Inclusion criteria: Children of both sex belonging to age group 3 to 12 years Patient presenting with the symptoms of Kasa Patient should have recurrence at least once in a month for minimum of six months

Exclusion criteria

Exclusion criteria: Patient presenting with symptoms of Tamaka shwasa (Bronchial asthma)Kshataja and Kshayaja kasa Patient presenting with Pneumonia COPD (Emphysema Bronchiectasis) Patient associated with systemic illness such as TB HIV and other chronic debilitating diseases

Design outcomes

Primary

Measure	Time frame
Changes in Subsidence of the clinical signs and symptoms Absence of recurrence during follow up Changes in hematological parameters and Biomarker indicesTimepoint: 8 weeks	—

Secondary

Measure	Time frame
Changes in general health conditions like height Body weight Agni Bala Deha Bala Chetas BalaTimepoint: 16 weeks	—

Countries

India

Contacts

Public ContactDr Rajagopala S

drkspatel2007@yahoo.co.in02882552014

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026